查詢結果分析
來源資料
相關文獻
- Home-based Patient-controlled Epidural Analgesia with Bupivacaine for Patients with Intractable Herpetic Neuralgia
- A Comparative Study of the Safety and Efficacy of 0.5% Levobupivacaine and 0.5% Bupivacaine for Epidural Anesthesia in Subjects Undergoing Elective Caesarean Section
- Ropivacaine-Induced Convulsion Immediately after Epidural Administration-- A Case Report
- 無痛分娩
- 硬脊膜外麻醉導致下半身癱瘓:病例報告
- Combination of Bupivacaine Scalp Circuit Infiltration with General Anesthesia to Control the Hemodynamic Response in Craniotomy Patients
- An Alternative Continuous Caudal Block with Caudad Catheterization via Lower Lumbar Interspace in Adult Patients
- Local Supplementation of Ketoprofen Reduces the Incidence of Low Back Pain after Lumbar Epidural Anesthesia
- Epidural Anesthesia Combined with Propofol Sedation for Abdominal Hysterectomy in a Patient with Amyotrophic Lateral Sclerosis--A Case Report
- 術前及術中經硬脊膜外腔注射嗎啡對椎間板切除術有良好之術後止痛效果
頁籤選單縮合
題 名 | Home-based Patient-controlled Epidural Analgesia with Bupivacaine for Patients with Intractable Herpetic Neuralgia=居家方式硬脊膜外病人自控式止痛術應用於頑固性皰疹神經痛 |
---|---|
作 者 | 蔡玉娟; 王立楷; 陳炳碩; 陳翰平; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 99:8 2000.08[民89.08] |
頁 次 | 頁659-662 |
分類號 | 416.5 |
關鍵詞 | 硬脊膜外; 病人自控式止痛術; 頑固性皰疹神經痛; 局部麻醉劑; Herpetic neuralgia; Patient-controlled epidural analgesia; Local anesthetics; Bupivacaine; |
語 文 | 英文(English) |
英文摘要 | This clinical report is based on retrospective observation of the outcome and effects of patient-controlled epidural analgesia (PCEA) with bupivacaine infusion administered at home to five patients with intractable herpetic neuralgia. All patients had severe pain (9 or 10 visual analogue scale [VAS]points ) confined to the affected dermatomes, which was refractory to medication. The interval between zoster onset and PCEA application ranged from 27 to 60 days (mean, 37.2 d). The average daily amount of bupivacaine used was 36.5 to 91.2 mg (mean �b�nstandard deviation, 62.4 �b�n19.7 mg). The duration of PCEA therapy ranged from 10 to 28 days (18.4 �b�n7.6 d). One patient developed drug tolerance. All treatments resulted in effective and satisfactory pain relief (VAS, 0–3), with increase in physical activities to normal levels and easing of sleep and appetite impairment. No deleterious effects were found during PCEA therapy. After discontinuation of PCEA, two patients did not complain of pain but still had slight paresthesia, one of them required low-dose antidepressant for 17 days; three patients continued to have occasional sharp pain (VAS, 2–3) and required low-dose antidepressant and analgesic as-needed for one to six months. These results suggest that PCEA with bupivacaine infusion provides effective pain relief in patients with intractable herpetic neuralgia and is a feasible and effective home treatment modality with limited side effects. |
本系統中英文摘要資訊取自各篇刊載內容。